Outcomes

PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing

PreventionGeneticsis the perfect complement to Exact Sciences’ advanced cancer diagnostics portfolio and supports its entrance into hereditary cancer testing (HCT).

Outcomes

OmniSeq Received a Strategic Investment from HITACHI April 12, 2018

Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq.

Outcomes

MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018

Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics.

Outcomes

OmniSeq Received a Strategic Investment from LabCorp August 21, 2017

Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq Inc.

Outcomes

Access Regional Laboratory Business acquired by LabCorp June, 2017

Crosstree Capital Partners acted as exclusive financial advisor to Access.

Outcomes

Converge acquired by Quest Diagnostics October 7, 2013

Crosstree Capital Partners served as exclusive financial advisor to Water Street and ConVerge.